# The Effect of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery

> **NCT00788242** · NA · COMPLETED · sponsor: **Christoph Ellenberger** · enrollment: 200 (actual)

## Conditions studied

- Aortic Stenosis
- Coronary Heart Disease
- Heart Failure

## Interventions

- **DRUG:** Glucose-insulin-potassium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00788242
- **Lead sponsor:** Christoph Ellenberger
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2016-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00788242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00788242, "The Effect of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00788242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*